Tina Yong on MSN
Easy Ombre Gel Nail Art 💅🏻
In this video, learn how to create a pink and blue ombre nail art design at home using a variety of tools and products.
Is fiber the gut’s guardian angel or an over-hyped plant pulp we can happily skip? While carnivore enthusiasts swear their ...
The first global consensus on inflammatory bowel disease and pregnancy delivers clinician-focused, evidence-based guidance for real-world practice.
News-Medical.Net on MSN
Western diet fuels IBD by derailing the microbiome - can precision nutrition turn the tide?
This review examines how Western dietary patterns, high in ultra-processed foods, salt, and unhealthy fats, disrupt gut ...
Immunai collected a hefty $215 million series B round back in 2021 after raising $60 million through a series A earlier that same year. Those funds have helped the company stretch its reach from ...
The updated indication for the JAK inhibitor allows use in patients with moderately to severely active ulcerative colitis and ...
The Food and Drug Administration (FDA) has approved updated indications for Rinvoq® (upadacitinib) in the treatment of adults with moderately to severely active ulcerative colitis (UC) or Crohn ...
Exeter City footballer Jack Fitzwater has inflammatory bowel disease (IBD) Professional footballer Jack Fitzwater was "going to the toilet 20 to 30 times a day with blood in my stool" before being ...
With a fresh endorsement from the FDA, Johnson & Johnson has rounded out Tremfya’s presence in inflammatory bowel disease (IBD) and, in doing so, achieved a first for the IL-23 inhibitor drug class.
UK biotech OMass Therapeutics has revealed its first major pharma partnership, with Roche's Genentech unit paying $20 million upfront to tap into its expertise and find small-molecule therapies for ...
While Vedanta Biosciences waits for a phase 3 readout for its lead microbiome therapy based on live bacteria, an earlier-stage programme has failed a mid-stage trial. The Cambridge, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results